<DOC>
	<DOCNO>NCT01989832</DOCNO>
	<brief_summary>The prevalence renal acute rejection transplantation reduce thanks optimize use immunosuppressive drug . However , graft survival ten year improve since ; may explain part toxicity drug , viral infection , comorbidities ( diabetes , cardiovascular disease â€¦ ) . According transplant center , strategy combination immunosuppressive drug different , probably involve difference global cost patient management . There recommendation France establish similar practice . EPHEGREN observational , prospective , multicentric , pharmacoeconomic study renal transplant patient .</brief_summary>
	<brief_title>Pharmaco-economical Study Kidney Transplantation</brief_title>
	<detailed_description />
	<criteria>Patients first month renal graft , patient already include epidemiological French study ( EPIGREN ) 06 month period Men woman age 18 year Patients able exercise writing inform free consent participate biological collection Patients oppose collect medical data Patients register social security system Patients able complete questionnaire Patients age less 18 year patient guardianship Patients followup another center part study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>cohort</keyword>
	<keyword>pharmaco-economic</keyword>
	<keyword>kidney</keyword>
	<keyword>transplantation</keyword>
	<keyword>quality life</keyword>
</DOC>